DILAFOR
Dilafor AB is a Swedish drug development company focusing on the development of tafoxiparin for obstetric indications. The companyโs primary goal is to decrease the incidence of slow progress of labor both after induction of labor and after spontaneous onset of labor.
DILAFOR
Industry:
Biopharma Pharmaceutical
Founded:
2003-01-01
Address:
Solna, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.dilafor.com
Total Employee:
11+
Status:
Active
Contact:
+46 70 790 02 07
Email Addresses:
[email protected]
Total Funding:
51 M SEK
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Euro Microsoft Exchange Online Microsoft Azure DNS Fonts.com
Similar Organizations
Current Employees Featured
Per-Olov Eriksson
Per-Olov Eriksson Co-Founder & Head of Manufacturing @ Dilafor Co-Founder & Head of Manufacturing
Kjell Gunnarsson
Kjell Gunnarsson Co-Founder & Head of Non-Clinical Safety ,Toxicology @ Dilafor Co-Founder & Head of Non-Clinical Safety ,Toxicology
Erik Holmer
Erik Holmer Co-Founder & Head of R&D @ Dilafor Co-Founder & Head of R&D
Lena Degling Wikingsson
Lena Degling Wikingsson CEO @ Dilafor CEO 2011-02-01
Founder
Erik Holmer
Kjell Gunnarsson
Per-Olov Eriksson
Investors List
Praktikerinvest
Praktikerinvest investment in Venture Round - Dilafor
Rosetta Capital
Rosetta Capital investment in Venture Round - Dilafor
Ostersjรถstiftelsen
Ostersjรถstiftelsen investment in Venture Round - Dilafor
Official Site Inspections
http://www.dilafor.com
- Host name: dedserv4081.levonline.com
- IP address: 217.70.37.81
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm
Loading ...